Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Paragonix Develops Devices To Reduce Transplantation Transport-Related Failure

Executive Summary

Keeping organs designated for transplantation cool is vital to ensure procedure success. Medtech Insight spoke to Paragonix’s CEO, Lisa Anderson, to learn more.

You may also be interested in...



Cross-Country Trek Brings Hope To Transplant Candidates

Paragonix Technologies set a record for the longest transport of a donor lung to a patient. The company also completed a long-distance transport of a heart from the same donor.

Cardiovascular Catch-Up: J&J RF Balloon Ablation; Biotronik Home Monitor; And More

September has been full of cardiovascular technology news, including announcements from Biotronik and Biosense Webster. Here are a few of the highlights.

Minute Insight: Intel-Penn Tie-Up Proves Federated Approach’s Power

Federated learning has taken another step forward thanks to new research that proves it is better at spotting brain tumors. 

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT144436

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel